AtriCure (ATRC) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
July 29, 2025 4:01 PM EDTWorldwide revenue of $136.1 million an increase of 17.1% year over year (16.5% constant currency) Net loss of $6.2 million an improvement of $1.8 million year over year Adjusted EBITDA of $15.4 million an increase of $7.6 million year over year Generated $17.9 million of cash in the quarter Completed enrollment of all 6,500 patients in the ground-breaking LeAAPS trial
MASON, Ohio--(BUSINESS WIRE)--... More
